FIN Committee Session, 1/15/2026 #1
Finance Committee · January 7, 2026
Finance Committee briefing on Jan. 15 heard from the Prescription Drug Affordability Board on its cost-review work, preliminary affordability determinations for two diabetes drugs and related policy options, followed by a briefing from the Office of Financial Regulation on digital assets, virtual-currency kiosks, earned-wage-access and AI oversight.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No related articles available for this source.
